Thomas White International LTD Abbott Laboratories Transaction History

Thomas White International LTD

$468 Million
Q2 2023

A detailed history of Thomas White International LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Thomas White International LTD holds 8,176 shares of ABT stock, worth $927,812. This represents 0.19% of its overall portfolio holdings.

Number of Shares

8,176

Previous 8,176 -0.0%

Holding current value

$927,812

Previous $827,000 7.74%

% of portfolio

0.19%

Previous 0.18%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $434,271 - $511,637	-3,990 Reduced 32.8%	8,176 $980,000
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $192,570 - $209,846	-1,834 Reduced 13.1%	12,166 $1.33 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $916 - $1,112	-10 Reduced 0.07%	14,000 $1.52 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $94,181 - $120,540	-1,230 Reduced 8.07%	14,010 $1.28 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $37,692 - $55,116	-600 Reduced 3.79%	15,240 $1.2 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $332,018 - $369,614	-4,229 Reduced 21.07%	15,840 $1.38 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $106,392 - $115,362	1,300 Added 6.93%	20,069 $1.68 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $30,405 - $36,680	-500 Reduced 2.59%	18,769 $1.38 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $182,877 - $206,765	-3,250 Reduced 14.43%	19,269 $1.16 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $20,130 - $21,551	-375 Reduced 1.64%	22,519 $1.29 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.1 Million - $1.23 Million	22,894	22,894 $1.22 Million

Others Institutions Holding ABT

# of Institutions

3,196

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas White International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Thomas White International LTD with notifications on news.

Account

Thomas White International LTD Abbott Laboratories Transaction History